We use cookies to track usage and preferences. See Cookie Policy
Pocketmags Digital Magazines
AU
Pocketmags Digital Magazines
Christmas Presents
   You are currently viewing the Australia version of the site.
Would you like to switch to your local site?
Digital Subscriptions > Newsweek International > 24 February 2017 > RESISTANCE ISN’T FUTILE

RESISTANCE ISN’T FUTILE

Forget Democrats in Congress— meet the lawyers leading the real anti-Trump insurrection

@mattizcoop

BOB FERGUSON was ready. It was the end of January, and the Washington state attorney general had been concerned that President Donald Trump would soon issue a sweeping executive order targeting immigration. A bespectacled former chess champion, Ferguson had been plotting for weeks with various immigrant rights groups in the state about how to combat Trump’s i rst move. Then, on the last Friday in January, the White House issued its now infamous executive order targeting immigration from seven predominantly Muslim countries.

Ferguson was home that weekend but went into his oi ce to work on an appeal. His solicitor general, Noah Purcell, a former U.S. Supreme Court clerk, guzzled cof ee from a full-sized Starbucks box in his office, as opposed to the chain’s ubiquitous white cup. Within a day, they had lined up two of the state’s most prominent employers, Amazon and Expedia, to sign on, and soon they had persuaded a federal judge in Seattle to put the Trump ban on hold nationwide. Just before that ruling, Ferguson told Newsweek, “I’m going to keep going where the law takes me.”

READ MORE
Purchase options below
Find the complete article and many more in this issue of Newsweek International - 24 February 2017
If you own the issue, Login to read the full article now.
Single Issue - 24 February 2017
$7.99
Or 799 points
Annual Digital Subscription
Only $ 1.04 per issue
SAVE
87%
$52.99
Or 5299 points
Monthly Digital Subscription
Only $ 1.41 per issue
SAVE
81%
$5.99
Or 599 points

View Issues

About Newsweek International

THE WAR ON ALZHEIMER'S This aggressive attempt to prevent Alzheimer’s rather than treating it is the most exciting new development in decades, as well as a radical departure for researchers and the pharmaceutical industry. Traditionally, drug companies have tested their therapies on patients who already have memory loss, trouble thinking and other signs of dementia. It’s been a losing tactic: More than ninety nine percent of all Alzheimer’s drugs have failed tests in the clinic, and the few that have made it to the market only ameliorate some symptoms. No single medicine has been shown to slow the relentless progression of the disease. However this new approach, even partial success an appreciable slowing of brain degeneration could have a big impact, says Dr. Reisa Sperling, a neurologist who directs the Center for Alzheimer’s Researc.
Ways to Pay Pocketmags Payment Types
At Pocketmags you get Secure Billing Great Offers HTML Reader Gifting options Loyalty Points